期刊文献+

晚期糖基化终末产物与冠状动脉病变程度的相关性研究 被引量:4

暂未订购
导出
摘要 目的探讨晚期糖基化终末产物(AGEs)水平与冠心病(CHD)患者冠状动脉病变程度的关系。方法对132例行冠状动脉造影检查者,采用ELISA法测定血清AGEs水平。依照冠状动脉造影结果分为非冠心病组(n=38)和冠心病组(n=94),病变程度定量采用Gemini评分系统。根据冠状动脉病变支数,分为冠状动脉正常组(n=32)、单支病变组(n=34)、双支病变组(n=35)及多支病变组(n=31)。结合AGEs、Gemini积分对各组进行比较和综合分析。结果冠心病组血清AGEs浓度显著高于非冠心病组(P<0.01),随冠状动脉病变支数和Gensini积分增加血清AGEs水平相应升高。校正年龄、血压、血脂、血糖等影响后,AGEs与ISI、Gensini积分呈显著正相关(r=0.717、r=0.658,P<0.01),与冠状动脉病变支数亦呈正相关(r=0.742,P<0.05)。线性回归分析显示年龄、Gensini积分、BMII、SI是影响AGEs的独立因素;ISI、BMI、AGEs、年龄、SBP是影响Gensini积分的独立因素。结论血清AGEs在冠心病患者中明显升高,且随着冠状动脉病变程度加重而升高,提示AGEs不仅参与了冠心病的病理生理过程,而且还可作为判断冠状动脉病变严重程度的一项指标。
作者 骆世棠
出处 《实用临床医学(江西)》 CAS 2009年第6期30-32,共3页 Practical Clinical Medicine
  • 相关文献

参考文献7

  • 1李光伟.胰岛素抵抗评估及其临床应用[J].中华老年多器官疾病杂志,2004,3(1):11-12. 被引量:79
  • 2Kanauchi M,Tsujimoto N,Hashimoto T.Advanced Glycation End Products in Nondiabeticp-atients with Coronary Artery Disease[J].Diabetes Care,2001,24(9):1620-1623.
  • 3Sasso F C,Carbonara O,Nasti R,et al.Glucose Metabolism and Coronaryheart Disease in Patients with Normal Glucose Tolerance[J].JAMA,2004,291(15):1857-1863.
  • 4李丹,吕安林,贾国良.糖尿病对冠状动脉介入术后心功能的影响[J].心脏杂志,2005,17(4):362-364. 被引量:2
  • 5Lin R Y,Choudhurry R P,Cai W,et al.Dietary Glycotoxinspromote Diabetic at Herosclerosis in Apolipoprotein Edeficientmice[J].Atherosclerosclerosis,2003,168(2):213-220.
  • 6Cipollone F,Iezzi A,Fazia M,et al.The Receptor RAGE as a Progression Factor Amp Lifying Arachidonate-dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques:Role of Glycemic Control[J].Circulation,2003,108(9):1070-1077.
  • 7Zieman S,Kass D.Advanced Glycation End Product Cross-linking:Pathophysiologic Role and Therapeutic Target in Cardiovascular Disease[J].Congest Heart Fail,2004,10(3):144-149.

二级参考文献11

  • 1Van-Brussel BL, Voors AA. Venons coronary artery bypass surgery:a more than 20-year follow-up study [ J ]. Eur Heart J, 2003 , 24(10) :927 -936.
  • 2Nesto RW. Correlation between cardiovascular disease and diabetes mellitus : Current concepts [J]. Am J Med, 2004,116 ( Suppl 5 A ) :11S -22S.
  • 3Chakrabarti S,Charle SJ,Naglie G,et al. Alteration of endothelins:A common pathogenetic mechanism inchronic diabetic complications[J]. Int J Exp Diabetes Res,2002,3(4) :217 -231.
  • 4Perera MP, Maleszka A, Reiss N, et al. Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type2 diabetes[J]. Hum Reprod,2002, 17(2) :497 -502.
  • 5Smiseth A. Assessment of ventricular diastolic function [ J]. Can J Cardiol,2001,17 : 1 167 - 176.
  • 6宋剑波.老年Ⅱ型糖尿病患者的左心功能状况的探讨[J].中华现代医药,2003,3(2):126-127.
  • 7Senfort J. Cell therapy and gene therapy in diabetes mellitus [ J].MMW Fortschr Med,2004,146(20) :39 -40.
  • 8Bolognese L,Carmbba N. Angiographic findings fine course of regional and global left ventricular function,and clinical outcome in diabetic patients with acute myocardial infarction treated with primary percutancous transluminal coronary angioplasty[ J]. Am J Cardiol,2003,91 (5) :544 -549.
  • 9Orlic D,Kajstura J,Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium[ J]. Nature,2001,410:701 - 705.
  • 10曾国彬,张玉顺,贾国良.冠心病并发Ⅱ型糖尿病患者的冠状动脉造影特点[J].心脏杂志,2002,14(1):35-37. 被引量:22

共引文献79

同被引文献86

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部